Seek Benefit Analysis

The 2017 Tax Cuts and Jobs Act (TCJA) has significantly elevated the value of the R&D credit. A notable change brought forth by the TCJA is the requirement to amortize research expenses, beginning in tax years beginning January 1, 2022. Anticipated legislative changes may defer amortization until 2025, a common practice in tax law.

Congress often designates favorable provisions as temporary due to budget constraints, leading to yearly extensions. It's crucial to distinguish between general research costs addressed by the TCJA and those under R&D tax credit rules, which are much broader.

If the unfavorable tax treatment of research expenses persists, companies may face larger tax bills, accentuating the need for the R&D tax credit's invaluable benefits.

Research Economics in the Wake of TCJA Changes

Here are just a handful of ways in which the data from our reports can be employed.

Project Conceptualization

TCJA's impact on research expenditures is multi-faceted, particularly with regard to software development, which is now considered a research expense. Although the research credit remains unaffected, the economics of research are shaped in three key ways:

  • Shift in Accounting: Research expenses are no longer mere expenses. They are capitalized and amortized over five years (or fifteen for foreign research).
  • Changes to the 280C Election: Electing the reduced credit under §280C is no longer advantageous for many taxpayers. In 2022, without the election, the excess research credit over the current year's R&E amortization deduction reduces the amount of R&E capitalized. To gain any add-back, the research credit percentage must exceed 10%.
  • Elimination of Reasonableness Requirement: The §174 reasonableness requirement is eliminated, benefiting research-oriented firms.

These TCJA-driven modifications hold significant implications for the economics of research, prompting a strategic approach to maximize tax benefits and foster growth.

Required Shift in Accounting Methodology

The TCJA's impact on 2022 and subsequent tax years will likely prompt taxpayers incurring §174 experimental costs to adjust their accounting method. Form 3115 won't be necessary for 2022 instead, a detailed statement attached to their tax return will suffice for R&D expenditure amortization. No lookback adjustment or true-up is required for the change in the accounting method. Taxpayers will commence capitalizing and amortizing their 2022 R&D expenses.

In What Ways We Can Assist

Discover how expert team can mitigate the effects of §174 amortization by leveraging the R&D tax credit. If your business has incurred qualified research expenses while conducting eligible research activities, you qualify for this advantageous tax credit. Let us assist you in unlocking the full potential of this credit to maximize your tax benefits and boost your business growth.

Download Our Aerospace Case Study
Thank you! For Your submission
Click here to download your asset
Oops! Something went wrong while submitting the form.
Access Our Case Study on Consumer Goods Manufacturing
Thank you! For Your submission
Click here to download your asset
Oops! Something went wrong while submitting the form.
Download Our Comprehensive Metal Fabrication Case Study

To gain deeper insights into how our strategies and innovations have yielded remarkable benefits, please share your details.

Thank you! For Your submission
Click here to download your asset
Oops! Something went wrong while submitting the form.
Access Our Case Study on R&D Tax Credit for Precast Concrete
Thank you! For Your submission
Click here to download your asset
Oops! Something went wrong while submitting the form.

Which Industries Qualify?

The R&D tax credit can be applied to a wide variety of industries, including (but not limited to):

Aerospace

Tool & Die

Metal Fabrication

Plastics & Injection Molding

Consumer Products

Manufacturing

Architecture & Engineering

Food & Beverage

Financial Services

Mortgage & Banking

Software Development

Chemical

Contract Manufacturing

Construction / MEP

Pharma

Oil & Gas

Popular

By
Deb Roth
on
August 14, 2023

Maximizing Cash Flow Through Government Tax Opportunities

Amid the ongoing challenges posed by COVID-19, numerous small and midsize businesses are grappling with maintaining cash flow, operational capabilities, and their internal research and development initiatives. While the Coronavirus Aid, Relief, and Economic Security (CARES) Act did extend financial aid to these COVID-19-affected enterprises through emergency grants, retention tax credits, and forgivable loans, these solutions offer only temporary cash flow relief, falling short of providing lasting solutions.

By
Deb Roth
on
August 14, 2023

Understanding the R&D Tax Credit Carryforward Period

The R&D Tax Credit Carryforward Period refers to the duration during which unused portions of research tax credits can be applied to offset future tax liabilities. This provision is often overlooked by many taxpayers who are eligible for R&D Tax Credits. In most cases, companies that have qualified research expenses but lack current income can carry forward these credits to offset taxes on forthcoming profits. The carryforward period allows credits to remain applicable for up to 20 years. Additionally, the option to carry back credits for the previous year is also available.

By
Deb Roth
on
August 14, 2023

Are R&D Tax Credits Convertible to Cash?

Navigating the world of R&D Tax Credits often prompts the question: Can these credits be converted into cash refunds? It's a query frequently posed by businesses seeking to maximize their returns on research and development investments. While R&D Tax Credits themselves aren't inherently refundable, they can still yield a financial windfall in the form of cash benefits.

Have any question? We're here to help.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Cookie Consent

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.